Navigating GLP-1 Medications for Sleep Apnea: Insurance Realities, Clinical Efficacy, and Alternative Options
Sleep Hygiene
Main Facts The intersection of weight management and sleep medicine has entered a transformative era following clinical discoveries regarding glucagon-like peptide-1 receptor agonists (GLP-1s). Medications traditionally prescribed for type 2 diabetes and chronic weight management—such as semaglutide (marketed as Ozempic and Wegovy) and tirzepatide (marketed as Zepbound)—are demonstrating profound benefits for individuals suffering from obstructive … Read More “Navigating GLP-1 Medications for Sleep Apnea: Insurance Realities, Clinical Efficacy, and Alternative Options” »
